KNI-102

• Description:

  KNI-102 is a potent anti-HIV agent with an IC50 value of 100 nM for HIV protease[1].

• UNSPSC:

  12352005

• Target:

  HIV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/kni-102.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(N(CCC1)[C@@H]1C(NC(C)(C)C)=O)[C@@H](O)[C@@H](NC([C@H](CC(N)=O)NC(OCC2=CC=CC=C2)=O)=O)CC3=CC=CC=C3

• Molecular Formula:

  C31H41N5O7

• Molecular Weight:

  595.69

• References & Citations:

  [1]Mimoto T, et al. KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic. Chem Pharm Bull (Tokyo) . 1991 Nov;39 (11) :3088-90.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  139694-65-8